From January 5 to 7, 2024, the 4th China Hematology Development Conference was successfully held in Tianjin. Focusing on “Big Blood, Big Health, Big Health”, the conference focused on the key construction and core development directions of China’s hematology disciplines in the new era, carried out all-round, multi-dimensional and in-depth exchanges and discussions on cutting-edge hot spots in the field, and released the 2023 Important information in the field of hematology and the selection results of the top ten research advances in hematology in 2023.
This conference is the first time it has been held offline since the first Hematology Development Conference in 2021. The 3-day conference included 2 main forums, 21 special forums, 4 online special forums, 3 closed sessions and 1 special session. A total of 20 participants included academicians of the two academies, top scholars and managers in the medical and health field. More than 400 heavyweight guests in the field, including experts, delivered nearly 200 academic reports with distinctive themes, rich connotations, outstanding focuses, and colorful highlights. The cumulative number of offline participants exceeded 2,500. The conference was simultaneously broadcast live on the cloud through 28 platforms, attracting more than 7 million views from domestic and foreign hematology colleagues and the general public, setting off an upsurge of learning, attention and discussion in the field of hematology at the beginning of the year. Professor Huang Xiaojun, academician of the Chinese Academy of Engineering and director of the Institute of Hematology of Peking University, director of the Hematology Hospital of the Chinese Academy of Medical Sciences (Institute of Hematology of the Chinese Academy of Medical Sciences) and the Institute of Basic Medicine of the Chinese Academy of Medical Sciences (Basic College of Peking Union Medical College) Director Professor Cheng Tao, Chief Clinical Expert of the Hematology Hospital of the Chinese Academy of Medical Sciences (Institute of Hematology, Chinese Academy of Medical Sciences) and Director of the National Clinical Research Center for Blood System Diseases Professor Wang Jianxiang, Deputy Director of the Jiangsu Provincial Institute of Hematology Professor Wu Depei, Huazhong University of Science and Technology Professor Hu Yu, President of the Union Hospital Affiliated to Tongji Medical College and Director of the Institute of Hematology of Huazhong University of Science and Technology, and Professor Liu Bing, Director of the Institute of Hematology of the Fifth Medical Center of the PLA General Hospital, co-chaired the conference.
Vice Chairman of the Standing Committee of the National People’s Congress, Chairman of the Central Committee of the Chinese Peasants and Workers’ Party,
He Wei, Vice President of China Association for the Promotion of Peaceful Reunification, delivered a speech
Former Deputy Minister of Health,Deputy Chairman of the Education, Science, Culture and Health Committee of the National People’s Congress,Liu Qian, President of the Chinese Hospital Association, delivered a speech
Gao Guangming, deputy director of the Department of Medical Emergency Response of the National Health Commission, delivered a speech
Vice President of the Chinese Academy of Engineering,Chinese Academy of Medical Sciences and Peking Union Medical College
PrincipalAcademician Wang Chen delivers a speech
Wang Xu, member of the Standing Committee of the Tianjin Municipal Party Committee and Secretary of the Education Working Committee of the Municipal Party Committee, delivered a speech
Secretary of the Party Committee of the Chinese Academy of Medical Sciences and Peking Union Medical College Medical College,Vice President
Yao Jianhong presided over the opening ceremony
Hematology Hospital, Chinese Academy of Medical Sciences (Institute of Hematology, Chinese Academy of Medical Sciences),Chang Zikui, Secretary of the Party Committee of Tianjin Medical and Health Research Institute, delivered a speech
The report of the 20th National Congress of the Communist Party of China clearly pointed out that people’s health is an important symbol of national prosperity and national strength. Health is an inevitable requirement for promoting the all-round development of people, a basic condition for economic and social development, an important symbol of national prosperity and national prosperity, and a common pursuit of the development of human society. Facing people’s life and health, hematology, as one of the most important breakthroughs and application fields of modern biotechnology, has opened up an important frontier of clinical medicine. In the keynote report session of this conference, through wonderful reports with grand vision and far-reaching intentions, we can build consensus, stimulate momentum, clarify paths, and point out the direction for the high-quality development of hematology in my country in the new era.
Chen Zhu, Vice Chairman of the Standing Committee of the 13th National People’s Congress, Academician of the Chinese Academy of Sciences, President of the Red Cross Society of China, and Lifelong Professor of Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, delivered a keynote report on “Promoting the Spirit of Scientists and Promoting Innovation in Hematology”
Vice President of the Chinese Academy of Engineering,President of Chinese Academy of Medical Sciences and Peking Union Medical CollegeAcademician Wang Chen writes “Post-Graduation Medical Education: Career Development of Specialist Physicians”
Zhang Xuezhuo, academician of the Chinese Academy of Engineering, member of the Chinese Academy of Medical Sciences, and secretary of the Party Committee of Harbin Medical University, gave a keynote report on “From Pathogenic Genes to Genetic Disease Treatment”
Professor Cheng Tao, Dean of the Hematology Hospital of the Chinese Academy of Medical Sciences (Institute of Hematology, Chinese Academy of Medical Sciences) and Director of the Institute of Basic Medicine of the Chinese Academy of Medical Sciences (School of Basic Medicine, Peking Union Medical College), wrote “Exploring Medical Science and Technology Innovation Model and Promoting Hematology Discipline” High-Quality Development” keynote report
Important information released in the field of hematology
Looking back on 2023, our colleagues in the field of hematology have united their hearts and souls with the spirit of the 20th National Congress of the Communist Party of China, focused on the urgent needs of people’s health, implemented independent innovation in the discipline, improved key technologies in the field, served the national strategic needs, and contributed to the hematology workers of wisdom and strength. Professor Hu Yu, Dean of the Union Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology and Director of the Institute of Hematology of Huazhong University of Science and Technology, comprehensively reviewed the “Important Monographs”, “Guidance Consensus”, “National Platform”, “Made in China” and “Collaborative Innovation”. Important information in the field of hematology in 2023 was reviewed and released.
1+N roundtable dialogue
The deep integration of industry, academia, and research is the core content and important implementation form of innovation-driven development. In order to further deepen pragmatic cooperation and promote collaborative innovation and development, the conference specially set up a “1+N roundtable dialogue” session, inviting leading experts in hematology and medical circles, scientific circles, industry and other related fields to work together to ignite new engines of development. Provide suggestions and suggestions for the high-quality development of the hematology discipline. Professor Ma Jun, Director of the Harbin Institute of Hematology and Cancer, presided over the roundtable dialogue. Zhang Minghui, Vice President of Qilu Pharmaceutical Group, Ren Ruibao, Director of Shanghai Hematology Institute, Huang Wei, Chief Medical Officer of CSPC Pharmaceutical Group, and Deputy General Manager of Jiangsu Hengrui Pharmaceutical Co., Ltd. Lu Yun, Yang Rui, co-executive officer of Asymchem Pharmaceutical Group, Cheng Linzhao, chair professor of University of Science and Technology of China, and Zhu Tao, co-founder of CanSino Biologics, participated in the roundtable dialogue.
Top Ten Research Progress in Hematology in China in 2023
Professor Zhou Jiaxi, deputy director of the Institute of Radiation Medicine, Chinese Academy of Medical Sciences, deputy director of the National Key Laboratory of Blood and Health, and deputy director of the Haihe Laboratory of Cell Ecology, presided over the release of the top ten research advances in hematology in China in 2023. The top ten research advances in hematology in China released for four consecutive years have received widespread attention and high recognition from many clinical and scientific researchers. They comprehensively demonstrate the high-level research strength of China’s hematology disciplines, effectively promote the high-quality innovative development of hematology disciplines, and fully inspire Doctors and scientific researchers in the field of hematology further shoulder their mission and pursue excellence.
From January 5th to 7th, the conference closely followed international hot spots and was based on practical needs. It held 21 special forums, 4 online special forums, 3 closed-door meetings and 1 special meeting in parallel, focusing in depth on leukemia and lymphoma. /Myeloma, MDS/MPN, red blood cell diseases, coagulation diseases, children’s hematology, transfusion medicine, stem cell transplantation, infection and immunity, hematology care, hematology quality control, precision diagnosis of hematology, integrated rehabilitation of hematology and tumors, clinical use Focus topics such as blood area security, comprehensively explore basic frontiers, CAR-T frontiers, immune cell therapy, gene therapy, CGT scientific supervision, laboratory medicine frontiers and other hot topics, and share multiple perspectives through journal forums and youth forums to promote open sharing. Inspire innovative thinking.
For the general public who are concerned about the field of hematology, educators engaged in the field of hematology, young students interested in the field of hematology, as well as developers and managers in the field of hematology, this conference has specially opened science forums, medical education, and operation management , 4 online forums on new drug research and development, jointly discuss hot topics through a more flexible meeting format, better meet public health needs, broaden the boundaries of medical services, assist in the construction of talent echelons, and promote the development of health care.
Professor Cheng Tao, chairman of the conference, summarized the conference. He said that this conference will focus on the core development direction of hematology, as well as the major disciplinary issues faced in basic research, translation and clinical diagnosis and treatment of hematology in the new era, and carry out hot and cutting-edge sharing and in-depth discussions, covering everything from basic research to clinical diagnosis and treatment. Regarding all aspects of science popularization and guidance, the offline venue was packed with guests and friends. Online viewing exceeded 7.45 million, setting a new record high. The conference achieved improvements in scale, activity content, academic exchanges, cooperation and sharing, etc., and achieved fruitful results and extensive social influence. He emphasized that 2024 is a year of coexistence of opportunities and challenges. The Institute of Blood Research will continue to benchmark against top international medical research institutions, give full play to the advantages of the vanguard of blood system diseases and the national team, and work with colleagues in the field to focus on disciplinary development needs and key field issues, strengthen basic research, carry out standardized clinical research, and promote Transform scientific and technological achievements, strengthen the planning and layout of China’s hematology disciplines, and jointly draw a grand blueprint for the construction and development of China’s hematology disciplines.
This conference is hosted by the Peking Union Medical College of the Chinese Academy of Medical Sciences, the Hematology Hospital of the Chinese Academy of Medical Sciences (Institute of Hematology of the Chinese Academy of Medical Sciences), the Tianjin Institute of Medical Health of the Chinese Academy of Medical Sciences, the National Key Laboratory of Blood and Health, and the National Blood System Diseases Clinical Medical Research Center, Cell Ecology Haihe Laboratory, Central Committee of the Peasants and Workers Party for the Construction of a Healthy China, “Chinese Journal of Hematology” magazine, Chinese Physiological Society Blood Physiology Professional Committee, Chinese Hospital Association Hematology Institutions Branch, Tianjin Blood and Regeneration Organized by the Medical Association, Blood Science, and Gaobo Medical Group. More information about the conference will be obtained through Xinhua News Agency, CCTV Client, China Central Broadcasting Network, People’s Daily Online, Science and Technology Daily, Health News, China Medical Tribune, Physician News, Tianjin Daily, Jinyun, Beifang.com, Yimaitong, CCMTV, Oncology ? Hope, the medical community, Metz Medical, Good Doctors, Bo Medical and other media and public accounts such as the National Clinical Medical Research Center for Blood System Diseases, Tianjin Institute of Medical Health of the Chinese Academy of Medical Sciences, Cell Ecology Haihe Laboratory, and Blood Science continue to Report, welcome to pay attention.